巨头重金入场

药视声Medispace
Nov 05

▲定档11月!第二届ADC&新型抗体药物工艺控峰会重磅来袭!一度被视为创新“红海”的COPD治疗领域,如今成为跨国药企眼中的香饽饽。短短四个月,超过237亿美元的资金涌入这个领域——GSK与恒瑞医药达成120亿美元合作、默沙东约100亿美元收购Verona Pharma、罗氏10.7亿美元引进荃信生物双抗、GSK再以超7亿美元获得siRNA药物全球权利。热潮背后,必有逻辑。随着肿瘤和自免领域同质化...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10